Eagle’s Eye View: Your Weekly CV Update from ACC.org (Week of Dec. 12)
In this week’s View, Dr. Eagle discusses a systematic review and meta-analysis of aortic stenosis progression, then looks at a meta-analysis of randomized trials on the use of dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk. Finally, Dr. Eagle explores the three-year results of the SUCCOUR trial that investigated cardioprotection using strain-guided management of potentially cardiotoxic cancer therapy.
Clinical Topics: Acute Coronary Syndromes, Cardio-Oncology, Heart Failure and Cardiomyopathies, Invasive Cardiovascular Angiography and Intervention, Noninvasive Imaging, Prevention, Valvular Heart Disease, Novel Agents, Acute Heart Failure, Interventions and ACS, Interventions and Imaging, Interventions and Structural Heart Disease, Echocardiography/Ultrasound, Hypertension
Keywords: Acute Coronary Syndrome, Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors, Hemorrhage, Aortic Valve Stenosis, Heart Valve Diseases, Hemodynamics, Anthracyclines, Trastuzumab, Angiotensin-Converting Enzyme Inhibitors, Cardiotoxicity, Ventricular Dysfunction, Left, Heart Failure, Adrenergic beta-Antagonists, Neoplasms, Diabetes Mellitus, Echocardiography, Hypertension, Angiotensins
< Back to Listings